Investment Q&A

Q: Hi Peter/Ryan, I have 1000 shares of GXU or a .21 % position (currently at a loss) in my TFSA account and was wondering if it would be worth adding to it. Do you think there is potential here and is it worth buying. Thanks

Q: Hi

Could this be a situation where a buy out could be in the works?

ECN Capital Announces Review of Strategic Alternatives

Thank you

Mike

Q: Hi (again) 5i,
Thanks for your answer to my question on CTS earlier today, which I appreciate. Just some quick follow up: You write that CTS is likely worth holding "at least until completion of the review". If a sale of CTS - which would be very public information - is not negotiated, when would it be known that the review has been completed? Would that be required disclosure in the first quarterly report after the review terminated, or is that something management can keep under its hat for as long as it sees fit?
Thanks (again)!
Peter

Q: Can you comment on the quarter, would you buy here? or would buy QiPT at this time?

Q: Hi,

This stock has been very volitile the last couple of weeks. There was a particularly large drop las week.
Do you have any insight about what's going on?

Regards,
Dave

Q: Digitial Bridge is being sold pretty hard by another advising source, but their stock price is being crushed. I like their assets (digital infrastructure) but stock performance is lagging.

Opportunity, or ???

Q: Hi 5i,
CTS in my TFSA has been a bit of ride. In mid 2021 I was way up but held on the premise that selling winners leaves only losers, and there weren't dark clouds on the horizon - at least not that I saw. Now I'm way down. It's been a big swing.
I was pleased to hear the rumblings about a possible sale of CTS, as I'm sure many others may have been, but that unrewarded optimism has now made me, and others too perhaps, feel disappointed and even manipulated - definitely not good investor sentiment.
I glean from your recent answers to questions involving CTS that you think it's worth holding and I'm willing to do that, although the opportunity cost of having that money tied up waiting for a CTS rebound frustrates me.
So my question is simply, what is there about the future prospects of CTS that makes it a hold right now, and if there isn't a real positive response to the upcoming earnings announcement would it be time to sell, or is that too short term a view?
Thanks,
Peter

Q: I see you like CTS and would it be a good time to start a position now?
How are the insider positions? and have they been buying?
There where 3 deals delayed,is there any news about those deals?Might they have been cancelled all together after all?
You have any idea who could be possible candidates for a possible take over?

Q: Hi 5i Team,

If not already asked, pls comment on Aecon Group qtr earning , and this company going forward.

Thanks as always.

Q: Do you believe the current price weakness in Jamieson Wellness Inc. after the release of the Q4 2022 results presents a buying opportunity, or do you suspect that there could be further downside? Thank You

Q: Peter and His Wonder Team
BDI just reported a good quarter. The stock has moved to new highs. They seem to be doing very well in the recent past. However I am wondering how far can they go. I am up and wondering if I should just lock in my profits and be happy. Please give your thoughts on there future prospects. Thank you...your analysis is always helpful.

Q: I just read your January comments on this company and wonder if you are feeling any more positive about this company now.
Thanks for your response. Lesley

Q: Hi 5i,
Is there a way to know if Morgan Stanley issued the recent unsecured note at 12% for one year to Novo Integrated Sciences (a US micro cap in the health sciences sector)?
Tia

Q: I know you have dropped SYZ from your income portfolio but the price is on the low end, I am looking at it for growth as opposed to income. At this price, do you think it's a good buy with growth potential

Q: From ANRG's perspective, how do you view Enbridge's foray into RNG via its $1 billion commitment to Divert Inc?

Is it positive because it lends credibility to the market, or negative because the did not buy/fund/partner with/ or license technology from ANRG?

Thanks,

Q: Thank you for the article "Good things come in small packages: Why we like small and mid-cap US stocks."

Is there a way of factoring riskiness of SMID-Caps vs Large Caps either qualitatively or quantitatively into your discussion and would you care to elaborate?

Q: PHX has seemingly released just stellar results, why there are no market activities to reflect that? No buy or sells and no noticeable SP movements? Thanks.

Q: In a couple of recent (March 3 posted) questions today you have suggested in some portfolio cleanups, letting AT go and also STC with proceeds to be consolidated into CTS. However, at least to-date, the 5i Growth Portfolio is still holding both AT and STC. Can you elaborate please . Many thanks.

Q: Thoughts on recent results? Wondering whether to add to existing small position, or not. Thanks

Q: What are your thoughts on EXPI latest earnings report? Was there anything of particular interest on the conference call (either positive or negative)? The stock has been punished with interest rate hikes impacting real estate markets. Does it look like a company that will do well when it comes out of this and real estate picks up or have the fundamentals and story changed here? Is this an add while its down, hold and do nothing, or time to move onto other higher conviction names (please suggest any). Currently held in TFSA so no opportunity to claim a loss (down 70%, currently less than 1% weighting due to drop). Thanks so much!